For the latest
cancer COVID-19 resources, click on this link
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Brain & nervous system
Sign up for latest coverage
Submit your event
cancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Prevention & screening
Middle East and North Africa
Central America and the Caribbean
Australia and Oceania
18 - 22 Sep 2020
ESMO 2020: Sarcomas and GISTs roundup
ESMO 2020: 20-year research breakthrough offers new hope for breast cancer patients
ESMO 2020: Two-pronged attack using new targeted drug could treat ‘addicted’ prostate cancers
ESMO 2020: Immunotherapy combination improves outcomes in advanced kidney cancer
ESMO 2020: Immunotherapy is beneficial in gastric and oesophageal cancers
ESMO 2020: No benefit for post-operative radiotherapy in non-small-cell lung cancer
ESMO 2020: PARP inhibitor olaparib for the targeted treatment of metastatic prostate cancer
ESMO 2020: First new drug in years reduces recurrence in high-risk hormone receptor positive early b...
ESMO 2020: First-time data revealed from two studies evaluating pembrolizumab plus lenvatinib in sev...
ESMO 2020: Sacituzumab govitecan-hziy extends survival in phase 3 ASCENT study of metastatic triple-...
ESMO 2020: KRAS inhibitor sotorasib appears safe, achieves durable clinical benefit in early trial
ESMO 2020: New first-line treatment option for metastatic kidney cancer, according to results of pha...
ESMO 2020: Increasing the effectiveness of cancer treatments: Anti-PD-L1 immunotherapy
ESMO 2020: Access to cancer medicines and clinical trials show stark variations across Europe
ESMO 2020: COVID-19 pandemic halts cancer care and damages oncologists’ wellbeing